Insider Trading Alert - ENDP, AAPL And DTE Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, March 11, 2014, 134 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $363.00 to $110,557,762.60.

Highlighted Stocks Traded by Insiders:

Endo International (ENDP) - FREE Research Report

Higgins Arthur J who is Director at Endo International bought 5,000 shares at $73.00 on March 11, 2014. Following this transaction, the Director owned 5,000 shares meaning that the stake was reduced by 100% with the 5,000-share transaction.

The shares most recently traded at $73.05, up $0.05, or 0.07% since the insider transaction. Historical insider transactions for Endo International go as follows:

  • 12-Week # shares bought: 5,478
  • 12-Week # shares sold: 15,592
  • 24-Week # shares bought: 5,478
  • 24-Week # shares sold: 15,592

The average volume for Endo International has been 2.2 million shares per day over the past 30 days. Endo International has a market cap of $8.5 billion and is part of the health care sector and drugs industry. Shares are up 13.87% year-to-date as of the close of trading on Friday.

Endo Health Solutions Inc. provides specialty healthcare solutions in the United States and internationally. The company has a P/E ratio of 16.7. Currently there are 8 analysts that rate Endo International a buy, 1 analyst rates it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ENDP - FREE

TheStreet Quant Ratings rates Endo International as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, disappointing return on equity and weak operating cash flow. Get the full Endo International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Illumina Shares Spike on Strong Earnings, Upside Still Remains: Biotech Movers

Geron Shares Take a Dive After J&J Unit-Led Trial Falters; Endo Closes Higher: Biotech Movers

Top Ranking Democrat McCaskill Expands Probe into Opioid Crisis

Canadian Pharma Goes Before FDA Panel Wednesday on Tamper Resistant Opioid

3 Biotech Stocks on Readers' Minds